LivaNova (LIVN) Revenue (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.37% |
| Dec 31, 2025 | 0.89% |
| Sep 30, 2025 | 1.48% |
| Jun 30, 2025 | 11.26% |
| Mar 31, 2025 | -1.55% |
| Dec 31, 2024 | 1.17% |
| Sep 30, 2024 | -0.14% |
| Jun 30, 2024 | 8.02% |
| Mar 31, 2024 | -4.91% |
| Dec 31, 2023 | 8.39% |
| Sep 30, 2023 | -2.64% |
| Jun 30, 2023 | 11.56% |
| Mar 31, 2023 | -4.17% |
| Dec 31, 2022 | 8.82% |
| Sep 30, 2022 | -0.61% |
| Jun 30, 2022 | 5.82% |
| Mar 31, 2022 | -11.07% |
| Dec 31, 2021 | 6.65% |
| Sep 30, 2021 | -4.26% |
| Jun 30, 2021 | 6.82% |
| Mar 31, 2021 | -8.14% |
| Dec 31, 2020 | 12.28% |
| Sep 30, 2020 | 31.76% |
| Jun 30, 2020 | -24.83% |
| Mar 31, 2020 | -15.71% |
| Dec 31, 2019 | 7.07% |
| Sep 30, 2019 | -3.09% |
| Jun 30, 2019 | 10.51% |
| Mar 31, 2019 | -15.55% |
| Dec 31, 2018 | 9.15% |
| Sep 30, 2018 | -5.36% |
| Jun 30, 2018 | 14.82% |
| Mar 31, 2018 | -10.04% |
| Dec 31, 2017 | 10.79% |
| Sep 30, 2017 | -1.79% |
| Jun 30, 2017 | 12.79% |
| Mar 31, 2017 | -9.14% |
| Dec 31, 2016 | 4.67% |
| Sep 30, 2016 | -5.16% |
| Jun 30, 2016 | 11.65% |
| Oct 18, 2015 | -16.65% |
| Jul 24, 2015 | 9.37% |